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The interaction of DNA with proteins in the context of chromatin has to be tightly regulated
to achieve so different tasks as packaging, transcription, replication and repair. The very
rapid and transient post-translational modification of proteins by poly(ADP-ribose) has
been shown to take part in all four. Originally identified as immediate cellular answer
to a variety of genotoxic stresses, already early data indicated the ability of this highly
charged nucleic acid-like polymer to modulate nucleosome structure, the basic unit of
chromatin. At the same time the enzyme responsible for synthesizing poly(ADP-ribose),
the zinc-finger protein poly(ADP-ribose) polymerase-1 (PARP1), was shown to control
transcription initiation as basic factor TFIIC within the RNA-polymerase II machinery. Later
research focused more on PARP-mediated regulation of DNA repair and cell death, but
in the last few years, transcription as well as chromatin modulation has re-appeared
on the scene. This review will discuss the impact of PARP1 on transcription and
transcription factors, its implication in chromatin remodeling for DNA repair and probably
also replication, and its role in controlling epigenetic events such as DNA methylation and
the functionality of the insulator protein CCCTC-binding factor.
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POLY(ADP-RIBOSYL)ATION
Poly(ADP-ribosyl)ation as enzymatic reaction is known since the
early sixties of the last century (Chambon et al., 1963). In the
following 20 years it was related to several nuclear functions,
i.e., histone modification (Aubin et al., 1982), differentiation
(Farzaneh et al., 1982; Pekala and Moss, 1983), cell death (Sims
et al., 1983), transcriptional regulation (Slattery et al., 1983) and
DNA repair/genome stability (Davies et al., 1978; Durkacz et al.,
1980). Also the major players were analyzed:
(1) Structure of the product poly(ADP-ribose) (PAR) (Chambon
et al., 1966; Nishizuka et al., 1967; Reeder et al., 1967),
(2) Synthesizing enzyme poly(ADP-ribose) polymerase(−1)
(PARP1) [(Tsopanakis et al., 1976), cDNA cloned in
(Cherney et al., 1987; Suzuki et al., 1987)] and
(3) Degrading enzyme poly(ADP-ribose) glycohydrolase
(PARG) [(Ueda et al., 1972), cDNA cloned in (Lin et al.,
1997)].
In the enzymatic reaction NAD+ is cleaved into nicotinamide and
ADP-ribose, with the latter attached to glutamate or aspartate
via an ester bond (Ogata et al., 1980b), and to lysine, form-
ing a ketoamine by Schiff-Base and Amadori rearrangement
(Altmeyer et al., 2009). Whereas esters are enzymatically easy
to revert, ketoamines show substantial stability and may form a
“modification-mark” on the respective protein. After attachment
of the first ADP-ribose moiety, further units are rapidly added via
α-gylcosidic bonds and branches can originate from the growing
chain, depending on the synthesizing enzyme and interaction
partner (Naegeli and Althaus, 1991).
PARPs are nowadays a family of 17 enzymes, but not all of
them are active ADP-ribose transferases and only few show truly
polymerizing activity (Hottiger et al., 2010). In case of PARP1, the
product poly(ADP-ribose) displays a tree-like structure, form-
ing a highly negative charged cloud at the covalently modified
protein, which impacts on functionality probably through elec-
trostatic repulsion of affected enzymes from DNA (Zahradka
and Ebisuzaki, 1982). The main acceptor of PAR is PARP1 itself
(Ogata et al., 1981), but also its interaction partners can be mod-
ified, as shown for several nuclear proteins in vitro and in vivo.
Degradation of the polymer is performed by PARG in an endo- as
well as exoglycosidic reaction, releasing PAR of different length as
well as ADP-ribosemonomers (Meyer-Ficca et al., 2004; Bonicalzi
et al., 2005). Enzymatic activity of PARP1 is very low and PAR
in unstimulated cells has an estimated half-life of up to several
hours (Alvarez-Gonzalez and Althaus, 1989). After application
of DNA strand-break inducing agents, PARP1 dimerizes at the
break, leading to its activation (Mendoza-Alvarez and Alvarez-
Gonzalez, 1993; Jorgensen et al., 2009; Langelier et al., 2012).
PARP1 can also bind non-B-DNA structures (Soldatenkov et al.,
2002; Lonskaya et al., 2005; Potaman et al., 2005). PAR synthe-
sized in this process displays a much reduced half-life of less than
a minute as high local concentrations of the polymer stimulate
PARG activity (Alvarez-Gonzalez and Althaus, 1989).
Increased poly(ADP-ribosyl)ation (PARylation) metabolism is
one of the first cellular responses following exposure to geno-
toxic stress (Haince et al., 2007, 2008). In addition to covalent
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modification proteins can interact with PAR in a non-covalent
fashion. So far, three different motifs have been described:
First, a sequence of basic and hydrophobic residues, the so
called PAR-Binding-Motif (PBM) (Pleschke et al., 2000), which
is present in many proteins involved in maintaining genomic sta-
bility, i.e., telomerase, p53, histones, base-excision-repair (BER)
platform protein XRCC1, nucleotide-excision-repair (NER) pro-
tein XPA and many more.
Next, it was reported that the macro-domain binds in an end-
capping mode to the tip of a PAR chain (Karras et al., 2005).
Finally, a PAR-Binding-Zinc finger (PBZ) was discovered in
APLF, a histone chaperone (Ahel et al., 2008).
The wide-spread regulatory impact of PARylation has been
described in a recent publication (Gagne et al., 2012). A large scale
analysis of PAR-interacting proteins after application of genotoxic
stress revealed that specific proteins are associated with PAR in a
sequential way after challenge, with an early group representing
repair complexes, followed by translation regulators and finally
factors involved in RNA processing. Both principles, covalent and
non-covalent interaction, can be present side-by-side within one
protein. For example the tumor suppressor p53 displays three
covalent as well as three non-covalent binding sites (Fahrer et al.,
2007; Kanai et al., 2007). Interestingly, the interaction partner is
one determinant that affects complexity of PAR, i.e., chain-length
and branching (Naegeli andAlthaus, 1991). Additionally, proteins
differ in their ability to bind to different PAR structures (Fahrer
et al., 2007).
In summary, PARP1 (respectively its product PAR) is able
to change the surrounding environment by either excluding
modified proteins from distinct sites, or by attracting factors
containing PAR interaction-motifs.
PARP1 IN DNA-REPAIR AND REPLICATION
SINGLE-STRAND BREAK REPAIR AND HISTONE SHUTTLE
Activity of PARP1 has been correlated with DNA damage since it
was discovered (Miller, 1975a,b). DNA strand-breaks are strong
inducers of PARylation, stimulating the enzyme several hundred-
fold. The exact cellular function of this energetic costly reac-
tion was long unclear, but application of genotoxic agents with
simultaneous suppression of PARylation led to increased per-
sistence of breaks (Morgan and Cleaver, 1983), reduced repair
(Yamamoto andOkamoto, 1982) and enhanced sister-chromatid-
exchanges (Hori, 1981; Otsuka et al., 1983; Park et al., 1983;
Meyer et al., 2000), indicating that PARP1 activity is intimately
involved in maintaining genomic stability. As histones have been
reported early as covalent acceptors of PAR (Aubin et al., 1982),
disassembly of nucleosomes to facilitate repair was suggested.
Soon after this theory, in vitro experiments showed that puri-
fied PAR added to polynucleosomes was able to relax their
condensed structure (Poirier et al., 1982). This pointed to non-
covalent interaction between at least the linker histone H1 and
PAR. Indeed, affinity of H1 to polymer is strong enough to
resist phenol partitioning (Panzeter et al., 1992). In addition,
also core histones have been shown to be covalently (Ueda
et al., 1975; Ogata et al., 1980a; Messner et al., 2010) and non-
covalently (Adamietz and Rudolph, 1984; Kreimeyer et al., 1984)
modified.
These data led to the assumption that one of the major tasks
of PAR synthesis is to clear DNA from nucleosomes by direct
modification as well as binding of histones to polymer, grant-
ing access of repair factors to the lesion (Mathis and Althaus,
1987; Realini and Althaus, 1992). The detection of PBMs in his-
tones and many other proteins related to DNA repair and stress
response, i.e., tumor suppressor p53, cyclin-dependent kinase
inhibitor p21, base-excision- and single-strand break-repair pro-
tein XRCC1, nucleotide-excision repair protein XPA, DNA-Pol
, telomerase subunit TERT, Ku70 and mismatch-repair pro-
tein MSH6 (Pleschke et al., 2000), corroborated the hypothesis
of PARP1 as a repair and cell cycle regulator. This was con-
firmed in vivo by the fact that the BER adaptor protein XRCC1
(X-ray repair cross-complementing protein 1) depends on PAR
for its recruitment to lesions. Inhibition or knockout of PARP1
strongly impacts on XRCC1 enrichment at DNA strand breaks
(El-Khamisy et al., 2003). XRCC1 interacts as shuttle with pro-
teins necessary to perform the synthesis and resealing steps
after incision as DNA Polβ, polynucleotide kinase and DNA
ligase III. Direct interaction of PARP1 with DNA ligase III
may help in formation and guiding of the productive complex
(Leppard et al., 2003).
Thus, PARP1 and its activity are important regulators of DNA
nick-repair. Shortage of the substrate NAD+ or strong activa-
tion may limit efficiency of repair, as PARP1 binds tightly to
DNA breaks if no auto-modification takes place (Satoh and
Lindahl, 1992; Satoh et al., 1994), and hyperactivation may shift
the spectrum of PARP1 protein-substrates. This is in line with
studies showing increased genomic instability by application of
PARP inhibitors, and at least in vitro, PARP1 is able to inhibit
DNA polymerases α and β as well as DNA ligase II by cova-
lent modification (Yoshihara et al., 1985). This could represent
a regulatory mechanism to avoid futile repair attempts of cells
suffering from a high burden of DNA damage. PARP1 also inter-
acts and stimulates flap-endonuclease-1 (FEN1), responsible for
cleaving exposed DNA single strands (flaps) derived from strand-
displacement synthesis during BER or replication (Prasad et al.,
2001). Finally, the chromatin remodeler Alc1 (Ahel et al., 2009;
Gottschalk et al., 2009) and APLF1, a histone chaperone includ-
ing AP-endonuclease activity (Eustermann et al., 2010; Mehrotra
et al., 2011), are recruited and activated upon PAR binding, prob-
ably facilitating nucleosome disassembly and re-assembly before
and after repair process (Figure 1).
DOUBLE-STRAND BREAK REPAIR AND REPLICATION
PARP1 also regulates signaling in double strand break repair
(DSBR). Inhibition of PARylation hampers and delays activa-
tion of initiator PI3K-related kinase ATM (ataxia telangiecta-
sia mutated) (Haince et al., 2007), and ATM forms a complex
with PARP1 (Aguilar-Quesada et al., 2007). There is evidence
that also DNA-PK directly interacts with and is stimulated by
PARP1 (Ruscetti et al., 1998). The interaction of DNA-PK and
PARP1 is strengthened by the observation that suppression of
the activity of one of them negatively affects the functionality
of the other in vitro (Veuger et al., 2004). In addition to these
two important damage-signaling kinases, PARP1 has many over-
lapping interaction partners with WRN, a RecQ helicase with
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FIGURE 1 | Poly(ADP-ribose) polymerase1 in DNA repair. Binding to DNA
breaks and dimerization activates PARP1, which synthesizes poly(ADP-ribose)
(PAR) from NAD+, covalently modifying itself and neighboring proteins, i.e.,
histones (blue bars = histone H1, purple hexagons = core histones). Proteins
containing PAR interaction motifs (PBM = PAR binding motif, PBZ = PAR
binding zinc finger; Macro = macro-domain) are recruited to the site of
damage, whereas histones in the vicinity are displaced from DNA.
Auto-modification of PARP1 abrogates PARP1 DNA binding. Recruited
proteins like the XRCC1-complex containing PNK (polynucleotide kinase),
Polβ (DNA polymerase β) and Lig (DNA ligase III) are released from PAR
chains by degrading activity of PARG and can perform repair on the
nucleosome-free DNA. Histone chaperones as APLF and Alc1 may help in
disassembling and reassembling of histones on DNA. Binding of PAR to p53
(either covalent or non-covalent) as well as interaction of PARP1 and PAR
with proteins like ATM, DNA-PK and WRN regulate cell cycle progression
and replication.
exonuclease activity mutated in theWerner adult premature aging
syndrome. WRN is responsible for resolving DNA structures such
as Holliday junctions and repair intermediates. It participates in
BER, DSBR, replication and maintenance of telomeres, the latter
one by proper opening the protective t-loop. WRN and PARP1
directly interact and regulate each other (Adelfalk et al., 2003;
von Kobbe et al., 2003, 2004), and are able to form a complex
with the DNA-PK subunits K70/Ku80 (Li et al., 2004). In this
regard, it is interesting to note that FEN1 also interacts with
WRN in BER and at telomeres (Brosh et al., 2001; Sharma et al.,
2003), where also PARP1 activity is needed to maintain proper
length (Beneke et al., 2008). Another cellular site were all three
proteins—FEN1, WRN, and PARP1—are located together is the
replication complex (Sharma et al., 2004). It has been shown
that PARP1 modifies at least 15 different proteins in the com-
plex, most prominently DNA Polα, topoisomerase I (TopoI) and
proliferating cell nuclear antigen (PCNA), but it is unclear if
PARylation is needed for proper assembly of replication complex
or for regulation of its functionality (Simbulan-Rosenthal et al.,
1998). Poisoning of TopoI stalls replication forks, and reversal
of this depends on PARP1 activity (Ray Chaudhuri et al., 2012),
probably by reactivating TopoI and induction of repair (Malanga
and Althaus, 2004).
PARP1 IN TRANSCRIPTION
PARP1 ACTIVITY AS NEGATIVE CONTROLLER OF TRANSCRIPTION
Transcription by RNA Pol II is regulated in multiple ways, i.e., by
induced assembly of different specific transcription factor com-
plexes at susceptible promoters. In addition, general transcrip-
tion factors—named TFII followed by a letter—are needed for
proper transcription of any gene [see Thomas and Chiang (2006)
for review]. PARP1 has been isolated in 1983 as TFIIC, neces-
sary for suppression of transcription initiation at nicked DNA
(Slattery et al., 1983). Activated PARP1 abrogates formation of
the pre-initiation complex (PIC) (Oei et al., 1998b) by PARylating
the TATA-binding protein (TBP) (Oei et al., 1998a) and TFIIF
(Rawling and Alvarez-Gonzalez, 1997) (Figure 2A). Similarly,
specific transcription factors as YY1, p53, CREB, Sp1, and
NFκB are prevented from binding to their respective recognition
sequence if PARylated (Wesierska-Gadek et al., 1996; Oei et al.,
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FIGURE 2 | PARP1-activity mediated suppression of transcription.
(A) PARP1 as basal transcription factor TFIIC monitors DNA breaks in the
vicinity of promoters. Transcription machinery is disassembled at pre-initiation
complex formation due to modification of TBP (TATA-binding protein) and
TFIIF with PAR after DNA damage induction. Transcription is blocked (switch
from black arrow to blocked red arrow). (B) PARP1 in regulation of stem cell
differentiation. SOX2 weakly interacts with PARP1 (dashed double-headed
blue arrow). Phosphorylation (green lollypop) of PARP1 by kinase ERK1 leads
to auto-modification of PARP1. SOX2 DNA-binding and dimerization with
OCT4 is disrupted by interaction with PARylated PARP1. Transcription is
abrogated (switch from black arrow to blocked red arrow). (C) Positive impact
of PARP1 protein itself on transcription as co-activator of NFκB. At the NOS2
promoter, PARP1 is acetylated (brown lollypops) by p300 HAT (histone
acetyl-transferase), which also acetylates NFκB, and interacts thereafter with
NFκB subunit p50. Binding of co-activator Mediator to the complex is
stabilized by PARP1 and facilitates transcription. Loss of PARP1 and also
putatively its activation disrupts transcription complex. Transcription is
abrogated (switch from black arrow to blocked red arrow). (D) PARP1 as
co-activator and PARP1 activity as repressor. PARP1 complexes with NRF1
irrespectively of its own modification status (blue double-headed arrow).
Covalent modification of NRF1 with PAR (red arrow) disrupts the permissive
transcription complex containing DNA-PKcs/Ku70/Ku80 and TopoIIβ, releasing
NRF1 from DNA. Transcription is blocked (switch from black arrow to blocked
red arrow). The respective stimulus needs to be determined (question mark).
1997; Chang and Alvarez-Gonzalez, 2001; Mendoza-Alvarez and
Alvarez-Gonzalez, 2001). PARylation negatively controls also the
function of transcription factors essential in sex-determination
via SRY, and maintenance of “stem-ness” of cells via SOX2.
SRY (sex-determining region of Y) is the master regulator in
sex-determination and essential for testis development. SRY-
mediated transcription is severely impaired upon PARP1 stim-
ulation, as its covalent modification abrogates interaction with
its cognate DNA-binding sequence (Li et al., 2006). SOX2 acts
in concert with OCT4 in stem-cell maintenance. Both form a
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complex on respective promoters/enhancers, i.e., NANOG and
SOX2 andOCT4, leading to positive feedback control [for review,
see Kashyap et al. (2009)]. SOX2 interacts weakly with PARP1
on regulatory elements, but upon activation of PARP1, bind-
ing between both proteins is enhanced due to auto-modification
of PARP1 (Lai et al., 2012) (Figure 2B). Although SOX2 is not
a direct target of PARylation, SOX2 DNA-binding is inhibited,
leading to disruption of SOX2/OCT4 transcriptional complexes
and induction of differentiation. Hypothetically, this is achieved
by SOX2-PAR interaction, but formal proof is missing yet. This
sequence of events was described in embryonic stem cells treated
with retinoic acid: exposure to RA led to activation of FGF/ERK1
pathway resulting in increased PARylation of PARP1, probably
by phosphorylation of PARP1, which has been shown to acti-
vate the enzyme (Kauppinen et al., 2006; Cohen-Armon, 2007).
Thereafter, binding between SOX2 and PARP1 is enhanced due to
auto-modification, transactivator function of SOX2 is inhibited
and subsequently, differentiation of ESC is induced.
PARP1 PROTEIN AS POSITIVE CO-FACTOR IN TRANSCRIPTION
On the other hand, PARP1 is also a general activator of tran-
scription as it is identical with positive co-factor 1 (PC1)
(Meisterernst et al., 1997). Supporting this, PARP1 has been
shown to associate with RNA Pol II-dependent promoters in
open chromatin, whereas H1 is mainly found in heterochromatic-
like regions, making their presence on chromosomes mutually
exclusive (Krishnakumar et al., 2008). Specifically, E2F1 inter-
acts with PARP1 in order to induce expression of S-phase genes
such as DNA Polα/DNAprimase, RPA and E2F1 itself (Simbulan-
Rosenthal et al., 1999). DNA-binding or PARP1 activity is not
needed for this co-activator function (Simbulan-Rosenthal et al.,
2003). Similar to E2F1, another important transcription factor
depends on PARP1 protein for transactivator function: NFκB,
the master-regulator of immune-responsive genes (Hassa and
Hottiger, 1999) (Figure 2C). PARP1 and both subunits of NFκB,
p50 and p65, form a ternary complex, and without PARP1,
some genes targeted by NFκB are not expressed, for exam-
ple NOS2, coding for inducible nitric oxide synthase (Hassa
et al., 2001). PARP1 activity is dispensable for co-activator
function and may even inhibit NFκB-dependent transcription
due to interference with its DNA binding (Chang and Alvarez-
Gonzalez, 2001). There is evidence that effective NFκB-mediated
transactivation of genes has several layers of regulation. PARP1
acetylation by histone acetyl-transferase (HAT) p300 is a pre-
requisite for binding to NFκB subunit p50, and p300 also binds
and activates NFκB directly (Hassa et al., 2005). Additionally,
Mediator—another co-activator complex—interacts with both
NFκB and PARP1, synergistically enhancing NFκB transactivator
function.
A switch between co-activating and repressive function has
been described in insulin producing β-cells. At the Reg pro-
tein promoter PARP1 presence is necessary for transcription, but
activation by DNA strand breaks disrupts the complex and tran-
scription is silenced (Akiyama et al., 2001). In line, the master
transcriptional regulator of genes related to energy metabolism
and mitochondrial function, NRF1 (nuclear respiratory fac-
tor), is also controlled by PARP1 activity (Figure 2D). NRF1
binds PARP1 irrespective of auto-modification status, and PARP1
recruits the DNA-PK/TopoIIβ complex to NRF1-regulated pro-
moters for expression, i.e., of the cytochrome c gene (CYC). As
soon as NRF1 becomes a target for PARP1 activity, NRF1 loses its
ability to bind PARP1 and transcription of respective genes is shut
down (Hossain et al., 2009).
Thus, it seems a general feature that PARP1 functions as a
nuclear sensor of stress exposure, and upon stimulation of its
enzymatic activity by DNA breaks or phosphorylation, it shuts
down transcription. The PARP1 protein itself may act as positive
regulator for expression. In this way, a broad range of genes can
be repressed that are not necessary for proper response—or even
contradictory—to the imposed stress.
PARP1 ACTIVITY AS POSITIVE CO-FACTOR IN TRANSCRIPTION
However, transcriptional regulation by PARP1 grew more com-
plicated in 2002, when a groundbreaking work appeared in
Genes and Development and a follow up 2003 in Science, using
D. melanogaster as a model (Tulin et al., 2002; Tulin and
Spradling, 2003). Here, PARP1 activity is described to facilitate
transcription. D. melanogaster encodes in its genome only two
PARPs, one is similar to PARP5 (tankyrase) and the other shares
substantial degree of homology with PARP1 from other organ-
isms. In D. melanogaster, PARylation is needed during larval
development as well as in heat shock for activation of specific
genes, i.e., heat-shock protein Hsp70. Employing polytene chro-
mosomes it could be visualized that hormone application or
heat shock induced PARP1 activity, and that the synthesized
PAR opened chromatin structure, generating so called “puffs,”
which are areas of ongoing transcription. The mechanism was
further elucidated by Petesch and Lis (Petesch and Lis, 2008,
2012). The heat shock factor (HSF) binds to the Hsp70 pro-
moter, where a stalled RNAPol II resides, poised for transcription.
HSF recruits the HAT Tip60, which acetylates histone H2A, lead-
ing to its exchange (Figure 3A). PARP1 resides dormant at the
Hsp70 promoter and its activity is rapidly induced by Tip60,
either by the described histone switch or by direct acetylation.
Subsequently, PARP1 modifies itself and is released from the
promoter. Following this, histones are disassembled from the
DNA and trapped in the growing polymer chain, paving the way
for the RNA polymerase. Interestingly, mammalian cells contain
the PARP1-suppressive histone macroH2A1.1 in HSP70 genes
responsive to heat shock, whereas constitutive HSP70 promoters
lack this variant (Ouararhni et al., 2006). In addition, heat shock
induces expression of HSP70 dependent on PAR synthesis, point-
ing to a very similar regulatory mechanism. Thus, PARP activity
changes the surrounding chromatin by disengaging suppressive
nucleosomal DNA binding. In the following years, this feature
was extended to other factors than histones.
Similar to RA-mediated differentiation of ESC described
above, PARP1 activity is involved in differentiation of neuronal
stem cells, NSC, but this time as positive regulator of transcrip-
tion (Ju et al., 2004) (Figure 3B). In NSC, transcription factor
HES1 (Hairy/Enhancer of Split) is a negative regulator of gene
expression. It interacts with the TLE (transducin-like Enhancer of
split)/Groucho co-repressor complex. Groucho is able to recruit
histone deacetylases, forming suppressive chromatin marks on
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FIGURE 3 | PARP1-activity mediated stimulation of transcription.
(A) Chromatin modulation by PARP(1) activity. HSP70 promoter is silenced by
incorporated H2A variant (H2Av), blocking PARP(1) activity (blocked black
arrow from H2Av to PARP1). RNA Pol II complex is assembled at promoter
and poised for transcription, but specific nucleosome positioning halts RNA
Pol II activity (blocked black arrow from nucleosomes to RNA Pol II). Heat
shock induces the translocation of HSF (heat shock factor) to the HSP70
promoter and recruits the histone acetyl-transferase Tip60, which induces
replacement of H2Av against standard H2A by acetylation (brown lollypop).
Putatively, it could also target PARP1, similar to the situation at
NFκB-regulated promoters. Activated PARP1 is released from the promoter
and traps suppressive histones in the growing PAR chain, facilitating
transcription (switch blocked red arrow to black arrow). (B) PARylation
activates expression of differentiation-linked genes. Treatment of neuronal
stem cells with PDGF (platelet derived growth factor) induces activity of the
kinase CaMKIIδ. Phosphorylation of PARP1 (green arrow No. 1) stimulates
PARylation, leading to disassembly of the large co-repressor complex
including nucleolin, nucleophosmin, TLE, RAD50, TopoIIβ, PARP1 and HES1
at MASH1 promoter. Auto-modified PARP1 and HES1 recruit histone
acetyl-transferase CBP, and subsequent phosphorylation of repressor protein
HES1 by CaMKIIδ (green arrow No. 2) initiates transcription (switch blocked
red arrow to black arrow).
differentiation-linked promoters like MASH1. PARP1 is part of
this repressor complex, together with TopoIIβ, nucleophosmin,
nucleolin and Rad50. Initiation of signaling events inducing
differentiation by platelet-derived growth factor (PDGF) leads
to activation of calcium-dependent kinase CaMKIIδ, which in
turn is recruited to the MASH1 promoter and phosphorylates
PARP1. Phosphorylation activates PARP1 resulting in PARylation
of co-repressor proteins, i.e., TLE/Groucho, TopoIIβ, nucle-
ophosmin, nucleolin, Rad50, and PARP1 itself. Polymer-modified
proteins except PARP1 leave the complex and histone acetylase
CBP is recruited. Subsequently, HES1 is also phosphorylated by
CaMKIIδ, which turns this repressive transcription factor in an
activator of MASH1 expression. Addition of a PARP1 inhibitor
or a PARP1 mutant lacking polymerization activity (Glu988 to
Ala988) blocked differentiation.
Low levels of a similar repressor complex are found at the
17 β–estradiol (E2)-sensitive pS2 promoter, composed of PARP1,
TopoIIβ, nucleophosmin, nucleolin and HSP70 (Ju et al., 2006).
Treatment with E2 leads to a rapid increase of TopoIIβ and
PARP1 at the promoter, followed by recruitment of DNA-PK and
co-activator CBP, whereas co-repressors are lost from pS2 pro-
moter (Figure 4). Formation of double-strand breaks (dsb) by
TopoIIβ induces PARP1 activity and replacement of histone H1
with HMGB1/2, facilitating expression. Again, treatment with a
PARP1 inhibitor or usage of the same catalytic mutant as above
blocked pS2 activation.
There are several more examples for PARP1 activity driven
transcription. The repressor-activator switch has also been
described in context of chromatin-modulator protein DEK
(Gamble and Fisher, 2007). In a complex, DEK and PARP1
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FIGURE 4 | PARP1-switch from repressor to activator of pS2
expression. PARP1 is member of a large co-repressor complex with
nucleolin, nucleophosmin, HSP70, TopoIIβ, PARP1, and N-CoR.
17 β–estradiol (E2) application recruits estrogen-receptor (ER) to the ER
responsive element, where the nucleosome (E) is localaized. This
induces enrichment of TopoIIβ and PARP1 at the same site (E) and loss
at surrounding nucleosomes located upstream (U) or downstream at the
TATA-box (T). TopoIIβ induces DNA double-strand break at ERE (red
flashes), which activates PARP1 and leads to the disassembly of
co-repressor complex, putatively by PARylation. Additionally, DNA-PK
complex (DNA-PKcs/Ku70/Ku80) is bound to the interrupted DNA strand.
PARylation induces exchange of suppressive linker histone H1 against
permissive HMGB1/2 protein and recruits histone acetyl-transferase
(HAT) CBP.
suppress transcription in vitro on chromatinized plasmid tem-
plates. Addition of NAD+ relieves suppression as both DEK
and PARP1 are lost from template due to modification with
poly(ADP-ribose). This enables the recruitment of the Mediator
co-activator complex and subsequent transcription. PARP1 is also
localized at promoters of mitochondria-related nuclear genes for
DNA repair and transcription (Lapucci et al., 2011). Treatment of
cells with PARP inhibitors reduces mitochondrial DNA integrity
and as a consequence, expression of respiratory genes and ATP
production is compromised.
Of note, PARP1 regulates its own promoter, which resem-
bles that of TATA-less housekeeping genes. Upstream of the
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initiation site, there are racket-like inverted repeats, which are
able to form alternative stem-loops. These structures can be
bound and stabilized by PARP1, leading to abrogation of tran-
scription. Activity of the enzyme is not necessary for repression,
but would obviously release the suppression of the PARP1 gene
(Oei et al., 1994; Schweiger et al., 1995; Soldatenkov et al., 2002;
Vidakovic et al., 2009). In this way, PARP1 protein keeps itself at
a constant level.
POST-TRANSLATIONALMODIFICATIONS OF PARP1 IN TRANSCRIPTION
In summary, PARP1 is able to regulate transcription at several
levels. If PARP1 is in fact belonging to the group of general
factors of RNA-PolII transcription (the missing TFIIC) may be
questionable, but its interaction with several transactivator pro-
teins is without doubt. It can act itself as a co-activator of gene
expression, with the potential to abrogate transcription after
activation. In this way, genes are transiently silenced that are
either not needed for or may even interfere with an appro-
priate stress response in cells. Alternatively, PARP1 activity can
rearrange nucleosomal organization and facilitate thereby acces-
sibility of the promoter to transcription factors and RNA Pol
II. In this setting, PARP1 can either be specifically recruited
or may be switched from a co-repressor to a co-activator after
stimulation by post-translational modification [for review, see
also Kraus (2008)]. Indeed, PARP1 is targeted by many enzy-
matic activities. Most prominent is the auto-modification by
PARylation, inhibiting DNA-binding as well as enzymatic reac-
tion. Phosphorylation by ERK1/2 (Kauppinen et al., 2006; Cohen-
Armon, 2007), AMPK (Walker et al., 2006) and CaMKIIδ (Ju
et al., 2004) has been reported, stimulating PARP1. Acetylation
of PARP1 also increases activity (Hassa et al., 2005), whereas
SUMOylation seems to restrict protein-substrate targeting of
PARP1 (Masson et al., 1997; Messner et al., 2009; Ryu et al.,
2010). K48-Ubiquitination leads to degradation of PARP1 (Wang
et al., 2008; Martin et al., 2009), which is probably induced
by auto-modification of the enzyme (Kashima et al., 2012).
Interestingly, there is crosstalk between these modifications, as
SUMOylation inhibits PARP1 acetylation, thus diminishing its
co-activator function in NFκB transcription (Messner et al.,
2009), and for activation of the HSP70.1 promoter in mam-
malian cells an ordered sequence of PARP1 modifications has
been described (Martin et al., 2009): Heat shock induces acti-
vation and auto-modification of PARP1 residing at the HSP70.1
promoter, which recruits SUMOylating enzymes Ubc9 and PIASy
to this site, resulting in polySUMOylation of PARP1 and full tran-
scriptional activation of the HSP70.1 gene. SUMO-modification
in turn attracts ubiquitin-ligase RNF4, which subsequently tags
PARP1 for degradation. Promoters of inducible HSP70.1 and
HSP70.2, but not of constitutive HSP70.8, are enriched of his-
tone macroH2A1.1, which suppresses PARP1 activity. Heat shock
relieves suppression (Ouararhni et al., 2006), putatively via Tip60-
mediated acetylation of the histone as described in insect cells,
thus facilitating PARylation reaction.
PARP1 AND CTCF IN EPIGENETIC CONTROLLING
First evidence that PARP1 plays a role in epigenetic mechanisms
came from experiments utilizing PARP inhibitors. Treatment
of fibroblasts with 3-aminobenzamide (3AB), a first generation
PARP inhibitor with low potency, induced increased methyla-
tion of CpG islands in the Htf9 promoter (Zardo and Caiafa,
1998), and cells displayed a rise in number and density of hete-
rochromatic foci as well as genome-wide DNA-methylation (de
Capoa et al., 1999). CCCTC-binding factor (CTCF) is known
to bind regulatory regions that are hypomethylated, organizing
chromatin domains as insulator and transcriptional regulator, a
function which has been extensively described for the IGF2-H19
ICR (imprinting control region). Binding of CTCF to the non-
methylated maternal ICR-allele facilitates H19 transcription and
silencing of IGF2, whereas the paternal IGF2 gene is expressed.
Loss of CTCF function increases methylation marks in respec-
tive sites and vice versa (CTCF is topic of several review in this
special issue), i.e., in case of the H19 ICR not only the paternal
allele, but also maternal allele is methylated. Using theH19 ICR as
bait, CTCF was shown to be a prominent target of PARP1 activ-
ity, resulting in a molecular size shift from 130 kDa to 180 kDa
(Yu et al., 2004). Covalent modification of CTCF did not interfere
with its DNA-binding ability in contrast to many other proteins,
but on the opposite, lack of PAR due to 3AB treatment abrogated
its insulator function. Actually, CTCF bound to target sites was
associated with a higher amount of PAR than free unbound CTCF.
Soon after, another link between CTCF, PARP1 and
methylation has been discovered. It was shown that DNA-
methyltransferase 1 (DNMT1) binds to PARP1, mainly if PARP1
is auto-modified. Binding to PAR—probably via two putative
PBM—inhibits DNA methylation by DNMT1. Interestingly,
DNMT1 has a higher affinity to PAR than to DNA, as it is case for
histones (Reale et al., 2005). CTCF binds to DNMT1 itself, but
is unable to block DNMT1 activity, so it depends on recruited
PARP1 to abrogate DNMT1 function despite physical presence.
CTCF stimulates PARP1 activity even without nicked DNA, lead-
ing to an increase in PARylated PARP1 and CTCF (Guastafierro
et al., 2008). In addition, the 130 kDa form CTCF was shown to
bind PAR in a non-covalent manner (Figure 5) (Zampieri et al.,
2012). In contrast to the negative effect on DNMT1 activity, there
is evidence that PARP1 and PARylation are needed to maintain
expression of DNMT1 in mouse L929 fibroblasts. PARP1 and
PAR were detected at the DNMT1 promoter in conjunction with
DNMT1 but without CTCF, and loss of PAR by overexpression of
the degrading enzyme PARG severely reduced DNMT1 in cells by
silencing through promoter-methylation (Zampieri et al., 2009).
Thus, PARP1 activity maintains transcription at the DNMT1
promoter by keeping it clear of DNA-methylation marks inserted
by DNMT1 itself. However, an earlier publication by the same
group showed the opposite effect, even in the same cell system
(Zardo et al., 2002). Treatment of L929 cells with 2mM 3AB
resulted in twofold increased expression of DNMT1. Thus, it
seems that PARP1 inhibition and increased polymer degradation
by PARG overexpression may not be the same. With 3AB, PAR
formation is blocked, whereas increased PARG activity induces
faster loss of synthesized PAR. It could also be the other way
round, with low-dose 3AB not preventing basal PARylation and
high PARG activity leading to degradation of basal polymers.
Thus, results from these two approaches may not be directly
comparable.
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FIGURE 5 | Regulation of CTCF function by PARylation. (A) CTCF shows a
high variability in putative binding sequences. There are probably high-affinity
sites (greenpeaked line) and low-affinity sites (black peaked line), with the latter
one hypothetically only used if additional signals are present, for example
PARP1 bound to a stem loop. CTCF is in complex with DNMT1 (DNA
methyl-transferase 1). Binding to high-affinity sites may suppressDNMT1
activity directly (red cross), either by altered interaction after DNA-binding
(blocked red arrow) or by release of DNMT1 from complex (black arrow and
questionmark). Interaction of CTCFwith PARP1 on low-affinity sites stimulates
PARP1 activity, which covalently modifies itself and CTCF. DNMT1 is inhibited
(red cross) by binding to PAR via a PBM (PAR binding motif). Loss of PARP1
(dashed outline of PARP1 protein) or polymer releases suppression ofDNMT1,
and the CTCF recognition site is de novomethylated (red lollipops), omitting
further CTCF binding (C). Restructuring chromatin domainsmay be achieved by
simultaneoususageof two adjacentCTCF-PARP1 sites as shown in (B). As both
CTCF and DNMT1 contain PBMs, PAR chains may serve as “glue” between
the two complexes, stabilizing chromatin loops. Loss of PARP1 or its product
PAR disrupts chromatin domain organization, facilitating DNMT1 activity (C).
The connection between the four players PARP1, PAR, CTCF,
and DNMT1 has been elucidated in more detail for the differ-
entially methylated region 1 (DMR1) upstream of the Igf2 pro-
moter (Zampieri et al., 2012). The three proteins CTCF, PARP1,
and DNMT1 can dimerize with each other independently and
form together a ternary complex, even without polymer. Most
DNMT1 is associated with CTCF, whereas only a fraction of
cellular PARP1 is part of the complex. This complex binds to
unmethylated CTCF target sites only. At the DMR1, all three
proteins are detected, in conjunction with PAR. Overexpression
of PARG leads to disruption of the complex, loss of PARP1
and CTCF and de novo methylation of DMR1 by the still
bound DNMT1. The subcellular distribution of CTCF is also
under control of polymer formation (Torrano et al., 2006).
Differentiation of K562 myeloid cells induces translocation of
CTCF from the nucleoplasm to the nucleolus, accompanied by
reduction of rRNA synthesis and growth arrest. Fractionation
experiments revealed that the 180 kDa (modified) form of CTCF
was prevalent in nucleoli. Inhibition of PARylation by 3AB pre-
vented relocalization of CTCF to nucleoli upon stimulus and
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restored nucleolar transcription. Similar results regarding control
of rDNA transcription and nulceolar organization by CTCF and
PARylation have been described for Drosophila (Guerrero and
Maggert, 2011).
There are several examples for the impact of PARylation on
CTCF function. CTCF is necessary for proper expression of
tumor suppressors p16 (CDKN2A-INK4) and E-cadherin (CDH)
(Witcher and Emerson, 2009) and loss of CTCF or PARP1
represses transcription of these genes. Abrogating polymer syn-
thesis induces hypermethylation, binding of CTCF to respective
regulatory sequences is lost and p16 and E-cadherin genes are
silenced. In contrast, c-Myc expression was not affected by abro-
gating PARP1 activity. Also another tumor suppressor, p19ARF,
is under control of the CTCF-PARP1-PAR complex (Farrar et al.,
2010). Mutation of the potential PARylation attachment sites in
CTCF led to loss of insulator function in regulation of transcrip-
tion and imprinting, similar to application of a PARP inhibitor.
PARP1 binds wild-type and mutant CTCF with equal efficiency,
but only the wild-type version was able to maintain p19 expres-
sion, as well as proper methylation pattern at the H19 ICR. The
authors also showed that there are genomic hot spots of inter-
action between CTCF and PARP1. Despite earlier suggestions,
it appeared that both isoforms of CTCF, i.e., 130 kDa as well as
180 kDa, are ADP-ribosylated, but to a different extent. Whereas
the larger one contains long and putatively branched polymer, the
small isoform contains oligo(ADP-ribose), detected only by an
antibody with high affinity to short ADP-ribose chains. As not
only cell cycle inhibitors p16 and p19 are controlled by CTCF,
but also c-Myc (Lobanenkov et al., 1990; Gombert and Krumm,
2009), pRb (De La Rosa-Velazquez et al., 2007), p21 and p27 (Qi
et al., 2003), loss of CTCF function may support cancer forma-
tion and indeed, 87.7% of tested breast tumors showed alterations
in the ratio between PARylated 180 kDa and 130 kDa forms of
CTCF. Whereas normal breast tissue contains only the large iso-
form, both can be detected in tumor tissue. Interestingly, there is
transition from CTCF-180 to CTCF-130 in primary cultures from
breast tissue upon stimulation of proliferation and vice versa, i.e.,
growth arrest induces CTCF-180 (Docquier et al., 2009). This is
in line with the above described observation of (Torrano et al.,
2006). Despite general interaction between CTCF and PARP1
independently from other factors, CTCF function is not on all
sites impaired by abrogating PARylation.
DISCUSSION
PARP1 IN REPAIR
PARP1 regulating chromatin can be divided into two differ-
ent major subsets: one is characterized by no or low levels of
PARylation in unstimulated cells, the other by high levels of
PAR as cellular stress response, but the border between these is
somehow blurred. Stimulation by signaling pathways leading to
phosphorylation of PARP1 at specific promoters may result in
high local PARylation with no obvious change in overall poly-
mer abundance. So, to which group does it belong? Nevertheless,
massive PARylation after genotoxic stress results in changes in
chromatin, which may be specific for the surrounding informa-
tion or more general. Overall changes include the rearrangement
of nucleosomal structure by modification of core and linker
histones, which can be covalent (confined to the direct interaction
with PARP1) and non-covalent, reaching beyond the proteins’
localization by spreading of the PAR-“tree”. Thus, PARP1 activity
clears the way for repair enzymes and complexes (see Figure 1).
Additionally, the polymer is capable of attracting factors if they
contain one of the three PAR-interaction modules described so
far, which many proteins in DNA-maintenance pathways do.
Probably, binding to polymer traps and therefore enriches respec-
tive proteins at the site of DNA breaks, and subsequent release by
PARG activity enables repair of the damage. By combination of
these two functions in one enzyme, chromatin loosening and pro-
tein attraction, repair rates can be accelerated. Additionally, PAR-
synthesis activates the initiator kinase ATM. It has been suggested
that the shift from the catalytically inactive dimer to the active
monomeric form of ATM may be induced by chromatin alter-
ations due to DNA breaks (Khanna et al., 2001), and that inter-
action with the MRN complex (MRE11/RAD50/NBN)—which is
also a downstream target of ATM—aids in this (Assenmacher and
Hopfner, 2004). The discovery of a PBM in ATM, the modulation
of kinase activation by PARP inhibition and the reported direct
interaction between both proteins support the hypothesis that
local PAR-formation initiates the respective signaling cascade, as
polymer relaxes chromatin and is bound by ATM. Thus, blocking
PARP1 activity obviously slows down repair.
PARP1 IN TRANSCRIPTION
Amore specific way of mediating stress response by PARP1 activ-
ity is its participation in transcriptional regulation. Suppression
of transcription in a generalized way helps to avoid additional
damage induced by clash of complexes (RNA Pol II vs. DNA-
repair) or possible sequence-loss caused by melting the double-
strand during transcription in the vicinity of breaks. This may
be facilitated by the proposed role of TFIIC/PARP1 as suppres-
sor of nick-induced transcription via modification of basal TFs
like TBP, blocking formation of PIC. But as most data support-
ing this came from in vitro experiments, this actually may be
not the case in living cells. Alternatively, specific inhibition of
certain promoters can be achieved in triggering PARP1 activity
if the enzyme is present in the complex. Interaction with sev-
eral transcription factors such as YY1, NFκB or others has been
reported in several publications. Interestingly, there is mount-
ing evidence that PARP1 acts as a switch in these complexes. For
example, it is an essential co-factor of NFκB-mediated transcrip-
tion, but PARylation disrupts the transcriptionmachinery, at least
in vitro. Similarly, polymer formation interferes with YY1 or p53
DNAbinding. To complicate the whole situation, p53 displays not
only three covalent attachment sites for PAR, but contains also
three polymer-binding motifs. Covalent modification interferes
with respective DNA binding, but strikingly abrogates nuclear
export of p53 (Kanai et al., 2007); however, what is the purpose
of p53 binding non-covalently to PAR? One suggestion may be
the attraction and exchange of proteins at promoters. Aging and
correlated oxidative stress in rat liver cells leads at the androgen
receptor promoter to the exchange of positive co-factors includ-
ing PARP1 against transcriptional suppressors including p53 (Shi
et al., 2008). A hypothesis would be that stress-associated acti-
vation and auto-modification of PARP1 disrupts the permissive
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complex, and p53 is attracted by binding to synthesized polymer,
resulting in silencing of the androgen receptor gene. Alternatively,
retention of p53 in the nucleus may be achieved by interaction
with PAR without any direct modification.
In addition, PARP1 can be activated even in the
absence of DNA breaks by post-translational modifications.
Phosphorylation of PARP1 mediated by CaMKIIδ after PDGF
stimulation of neuronal stem cells initiates PAR synthesis at
HES1-suppressed promoters. As a result, co-repressor proteins
Groucho/TLE, nucleolin, nucleophosmin and TopoIIβ are
released and co-activators, for example CBP, are recruited,
inducing differentiation. Interestingly, PARP1 can still be
found at the promoter, suggesting localization of the protein
independent of its DNA-binding ability (Ju et al., 2004). If
TopoIIβ activity is needed in this sequence of events has not
been determined. Exchanging specific factors mediated by
PARP1 activity is also seen in response to other signaling events.
TopoIIβ dependent transcriptional activation is intimately
associated with PARylation upon strand-break formation and
subtle changes in nucleosome-positioning (Ju et al., 2006).
A PARP1/TopoIIβ/DNA-PK complex is recruited to the pS2
promoter upon stimulation of cells by estradiol and induces a
DNA break. This in turn activates the PARP1 protein residing at
the promoter as part of the repressor complex and modification
of histone H1, which is subsequently exchanged against HMGB1,
facilitating transcription. Unfortunately, the authors did not
show any data about if and when proteins are PARylated. Also,
the authors did not dissect the order of observed events, i.e.,
which is first: dsb formation by TopoIIβ or PARylation? They
proposed TopoIIβ as initiating enzyme, triggering PARP1 activity,
but failed to provide evidence for that. It could also well be that
binding of the ER-E2 complex induces formation of an aberrant
DNA structure by kinking the DNA, resulting in activation of
PARP1. Poly(ADP-ribose) would in turn release co-repressors
and H1 and recruit co-activators, i.e., DNA-PK. Subsequent
dsb formation by TopoIIβ could be necessary to enable DNA
binding of DNA-PK and integration of HMGB1/2 into the
complex. Of note, the suppressive complex at the pS2 promoter
also contained nucleolin and nucleophosmin in addition to
PARP1/TopoIIβ. Thus, these three proteins seem to be more
general interacting partners of PARP1 in transcription, with
nucleolin and nucleophosmin as suppressive factors, whereas
PARP1 and TopoIIβ can act as switches. In addition, activity
of TopoIIβ is dampened by PARP1 in mouse spermatogenesis.
Inhibition of PARP1 increases double-strand break formation of
TopoIIβ (Meyer-Ficca et al., 2011b), and necessary exchange of
histones against protamine for compaction is disturbed, resulting
in poor sperm quality and reduced fertility (Meyer-Ficca et al.,
2011a). As it seems, TopoIIβ and PARP1 have a more intimate
relationship in controlling chromatin and expression than
thought before.
PARP1, CTCF, AND DNMT1
PARP activity is needed to prevent spreading of heterochromatic
regions by inhibition of DNMT1. In addition, PARP1 interacts
with chromatin-domain organizing insulator and transcription
factor CTCF, which binds only to unmethylated DNA. This
implies that epigenetic regulation is mediated by the interplay
of PARP1, CTCF, and DNMT1. Lack of PAR/PARP1 or CTCF
enhances the activity of DNMT1. Thus, the ternary complex is
poised to change DNA-methylation patterns and subsequently
expression profiles. Probably only basic polymer synthesis is
needed for PARP1 mediated regulation of CTCF binding, as no
publications are so far available that report increased CTCF local-
ization to DNA after PARP1 activity stimulation. On the other
hand, reducing PAR-levels has a dramatic impact on CTCFs
DNA-binding, cellular localization and genomic methylation-
pattern. If CTCF is a direct target of PARP1 or may only be
recruited to PAR is still unsolved, as binding to PAR can be strong
and resist general separation procedures. Alternatively, the two
CTCF isoforms, i.e., 180 kDa and 130 kDa, may represent cova-
lently modified and PAR-bound CTCF, respectively. The question
is still unsolved why presence of CTCF on some genomic sites
depends on poly(ADP-ribose) and on others not. Hypothetically,
the high variability of CTCF binding sequences and the ability
of PARP1 to bind to secondary structures may give an answer:
binding of CTCF at weak interaction sites is only supported if
next to the CTCF docking site a stem loop is present, bound by
PARP1 (Figure 5A). Concomitant presence of the two proteins
stabilizes the complex and triggers PARylation, directly stimu-
lated by CTCF. DNMT1 is in most cases found in association
with CTCF and is therefore also recruited to the weak interac-
tion site. Binding to the polymer abrogates DNMT1 activity, but
the enzyme is poised to methylate DNA as soon as the polymer-
mark is lost (Figure 5C). At high-affinity sites, CTCF is able to
bind on its own and may inhibit DNMT1 directly or in con-
junction with other proteins. Alternatively, binding of CTCF at
this position may reduce affinity to DNMT1 with subsequent loss
of the methyl-transferase (Figure 5A). If two CTCF/PARP1 sites
are located in close proximity due to chromatin domain orga-
nization, covalently modified CTCF can induce loop formation
by interaction of its polymer-mark with the PBM of another
CTCF molecule at the second position (Figure 5B), a hypothesis
already raised in (Klenova and Ohlsson, 2005; Caiafa et al., 2009).
It has been shown that loop-formation is one prominent fea-
ture of CTCF mediated chromatin restructuring (Yusufzai et al.,
2004; Yusufzai and Felsenfeld, 2004). Auto-modified PARP1 in
turn may assist in this. DNMT1 could also be instrumental in
domain formation as its own PAR-binding motif may aid in sta-
bilizing the complex. If PARP1 or its product PAR is lost,DNMT1
is no longer inhibited and can methylate the respective DNA
sequence, abrogating CTCF binding. The hypothesis of CTCF
docking sites with different affinities under putative control of
PARP1 presence is supported by data presented in Witcher and
Emerson (2009). Whereas the PARylation-independent CTCF-
homology sequence in theMYC promoter displays only very weak
PARP1 binding and no recruitment of TopoIIβ, PARP1 strongly
interacts on its own with the PARylation-dependent p16/INK4
promoter together with TopoIIβ. Alternative models have been
suggested, in which CTCF is first bound to DNA and recruits
in a second step PARP1 to specific sites (Caiafa and Zlatanova,
2009). CTCF-induced PARP1 activity in turn attracts DNMT1
by binding to PAR chains. However, more recent data show that
all three proteins, CTCF, PARP1, and DNMT1, independently
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interact with each other, indicating putative complex formation
even in the absence of DNA (Zampieri et al., 2012). In addition,
the presence of PARP1 at the silenced p16/INK4 promoter in the
absence of CTCF (Witcher and Emerson, 2009) argues in favor
of the hypothesis that PARP1 independently binds to sites in the
vicinity of CTCF target sequences and regulates insulator function
in cases where binding of CTCF is weak.
CONCLUDING REMARKS
One major disadvantage in many newer studies tackling
PARylation in transcription and chromatin organization is
the use of the first-generation low-potency PARP1 inhibitor
3-aminobenzamide, and this in high doses, at which unspe-
cific effects cannot be excluded. There are several more suit-
able inhibitors available such as olaparib, which has been used
also in clinical trials. On the other hand, high doses of PARP
inhibitors may be needed to block also unstimulated physiolog-
ical PARylation. So far, no inhibitor dose-response curves have
been published, analyzing especially consequences for chromatin
re-organization. Adding to this, even measuring PAR levels in
unchallenged cells has not been possible so far.
A yet unsolved obstacle is the experimental discrimination
between covalent and non-covalent modification of proteins by
poly(ADP-ribose). Addition of chaotropic agents for separation
of unbound PAR from proteins may not always be successful, as in
some cases interaction is strong enough to resist phenol partition-
ing (Panzeter et al., 1992). Non-covalent interaction can be tested
by using purified PAR and recombinant proteins employing affin-
ity assays, but the question remains if the target is also covalently
modified. In vitro approaches to solve this problemmay yield false
positives, as test-tube conditions are unlikely to mirror the sit-
uation in a cell. This brings up the next question: what defines
a protein respectively a specific amino acid position as substrate
for PARylation? No consensus sequence has been determined yet.
This leaves room for speculation, for example if only appropriate
amino acids exposed in a specific 3D environment are targeted by
PARP1, independent of the actual primary sequence. Recently, a
MS-based method turned out to be effective in detecting cova-
lent modification of lysines in core histone tails (Messner et al.,
2010). Surprisingly, glutamates have not been found as targets
for PARylation, despite earlier work defining a specific glutamic
acid residue in histone H1 and in H2B as covalently modified by
poly(ADP-ribose) (Ogata et al., 1980a,b). This may result from
differences in the experimental approaches. Mutational analy-
sis of potential acceptor sites in p53 strongly suggests that at
least some glutamates are targeted by PARP1 (Kanai et al., 2007).
Nevertheless, using MS techniques seems to be the appropri-
ate step toward unraveling the nature of polymer target sites. In
this way, also changes in phosphorylation profiles of PARP1 and
PARG have been defined (Gagne et al., 2009).
Another problem arises from the combination of DNA-
damage dependent stimulation and activity-related chromatin-
modulating properties within one enzyme. To monitor the
interaction between proteins and DNA, the method of choice is
chromatin immunoprecipitation (ChIP). The sample processing
includes crosslinking of proteins to DNA by administering low
concentrations (about 1%) of formaldehyde to cells for a short
time, usually 10min. We proved now in a recent publication, that
this procedure induces DNA strand-breaks and damage signaling
itself, as detected by massive increase in PARylation and phos-
phorylation of H2AX (Beneke et al., 2012). This impacted on the
efficiency of immunoprecipitation as suppression of both γH2AX
formation and PARylation, or even PARylation alone changed
the obtained results. The observed reduction in ChIP yields was
specifically dependent on the monitored combination of pro-
moter and protein. Thus, data obtained so far may be only the
tip of the iceberg, as more subtle changes could be blurred by
ChIP-induced DNA breaks and resulting damage signaling.
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